U.S. Markets close in 5 hrs 20 mins

Herborium Group, Inc. (HBRM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0008-0.0001 (-11.11%)
As of 10:16AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0009
Open0.0008
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0008 - 0.0009
52 Week Range0.0000 - 0.0074
Volume34,239,099
Avg. Volume115,866,491
Market Cap1.762M
Beta (5Y Monthly)129.86
PE Ratio (TTM)0.01
EPS (TTM)0.1150
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Herborium To Develop Proprietary Protein Bar with Unique Skin Benefits and Weight Management Properties

    Enters $7.03 billion Global Protein Bar MarketHouston, June 28, 2021 (GLOBE NEWSWIRE) -- Houston, Texas , June 28, 2021 Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal products with a strong records of efficacy and safety, (Botanical Therapeutics®) announced today that it will be launching its new, proprietary protein derma - bar that combines the benefits of clear, healthy and youthful skin with healthy weight manageme

  • GlobeNewswire

    Herborium Sales for First Quarter 2021 rises 20% Debt decreased $500.000

    Houston, June 23, 2021 (GLOBE NEWSWIRE) -- Houston, Texas , June 23, 2021 Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal products (Botanical Therapeutics®) announced today that despite the COVID Pandemic and its impact on the economy, The company’s performance remains strong and future activities and plans for new products and partnership are in a full swing. First Quarter sales for 2021 grew 19.7% while gross profit i

  • ACCESSWIRE

    Goldman Small Cap Research Issues New Research Report on Herborium, Group, Inc.

    BALTIMORE, MD / ACCESSWIRE / March 30, 2021 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on Herborium, Inc. The Company is a fast-growing and profitable, innovative player in the fast-growing natural medicine and natural therapeutics markets.